Preferred Label : anilides;
MeSH definition : Any aromatic amide obtained by acylation of aniline.;
Wikipedia automatic translation : Anilide;
Wikipedia link : https://en.wikipedia.org/wiki/Anilide;
Is substance : O;
Origin ID : D000813;
UMLS CUI : C0003035;
ATC code(s)
ATC code(s)
Allowable qualifiers
Automatic exact mappings (from CISMeF team)
Record concept(s)
Related MeSH Supplementary Concept(s)
- 1045U85 [MeSH Supplementary Concept]
- AVL3288 [MeSH Supplementary Concept]
- C 1368 [MeSH Supplementary Concept]
- DC-S238 [MeSH Supplementary Concept]
- DC-S239 [MeSH Supplementary Concept]
- FK 3311 [MeSH Supplementary Concept]
- PMP-072 [MeSH Supplementary Concept]
- SRT3025 [MeSH Supplementary Concept]
- T 3095 [MeSH Supplementary Concept]
- T 3157 [MeSH Supplementary Concept]
- THZ531 [MeSH Supplementary Concept]
- UC 82 [MeSH Supplementary Concept]
- UC-781 [MeSH Supplementary Concept]
- UT-115 [MeSH Supplementary Concept]
- WZ4003 [MeSH Supplementary Concept]
- alkamin [MeSH Supplementary Concept]
- tubacin [MeSH Supplementary Concept]
Semantic type(s)
Any aromatic amide obtained by acylation of aniline.
https://www.has-sante.fr/portail/jcms/c_2908453/fr/cabometyx
https://www.has-sante.fr/portail/jcms/c_2908453/fr/cabometyx-cabozantinib-inhibiteur-de-tyrosine-kinase
2019
false
false
false
false
France
French
treatment outcome
cabozantinib
carcinoma, renal cell
adult
cabozantinib
antineoplastic agents
protein kinase inhibitors
administration, oral
guidelines for drug use
evaluation of the transparency committee
anilides
pyridines
---
https://www.has-sante.fr/jcms/p_3082106/fr/cabometyx
2019
false
false
false
France
evaluation of the transparency committee
cabozantinib
adult
treatment outcome
carcinoma, hepatocellular
cabozantinib
administration, oral
antineoplastic agents
protein kinase inhibitors
anilides
pyridines
---
https://www.e-cancer.fr/Expertises-et-publications/Catalogue-des-publications/Medicaments-ciblant-VEGFR-axitinib-cabozantinib-pazopanib-sorafenib-sunitinib
2019
false
false
false
France
Axitinib
cabozantinib
pazopanib
Sorafenib
Sunitinib
Drug-Related side effects and adverse reactions
Drug-Related side effects and adverse reactions
risk factors
patient education as topic
continuity of patient care
administration, oral
receptors, vascular endothelial growth factor
carcinoma, renal cell
drug interactions
pregnancy
Tyrosine Kinase Inhibitors
guidelines for drug use
Sorafenib
pazopanib
Axitinib
Sunitinib
cabozantinib
pyrimidines
sulfonamides
anilides
pyridines
pyrimidines
sulfonamides
anilides
pyridines
anilides
pyridines
pyrimidines
sulfonamides
---
https://ansm.sante.fr/tableau-marr/vismodegib
2018
false
false
false
France
French
patient education handout
risk management
vismodegib
pregnancy
handbooks
contraception
teratogens
pregnancy tests
vismodegib
forms
abnormalities, drug-induced
fertility
fetal death
embryo death
HhAntag691
embryo loss
anilides
pyridines
---
http://circulaire.legifrance.gouv.fr/index.php?action=afficherCirculaire&hit=1&r=42484
http://circulaire.legifrance.gouv.fr/pdf/2017/08/cir_42484.pdf
2017
false
false
false
France
French
legislation
insurance, health, reimbursement
hepatitis C, chronic
elbasvir-grazoprevir drug combination
dasabuvir
legislation, drug
antiviral agents
ritonavir
Product containing ombitasvir and paritaprevir and ritonavir in oral dose form (medicinal
product form)
ombitasvir
paritaprevir
direct acting antivirals
daclatasvir
administration, oral
Simeprevir
sofosbuvir-velpatasvir drug combination
ledipasvir, sofosbuvir drug combination
Multidisciplinary care conference (procedure)
Interdisciplinary medical team conference (procedure)
dasabuvir
ombitasvir
paritaprevir
daclatasvir
benzofurans
drug combinations
imidazoles
quinoxalines
Sofosbuvir
carbamates
Heterocyclic Compounds, 4 or More Rings
benzimidazoles
fluorenes
uridine monophosphate
uridine monophosphate
sulfonamides
uracil
uracil
anilides
macrocyclic compounds
---
https://www.has-sante.fr/portail/jcms/c_2775799/fr/viekirax-exviera
2017
false
false
false
false
France
French
evaluation of the transparency committee
drug combinations
administration, oral
hepatitis C, chronic
drug therapy, combination
adult
anilides
carbamates
antiviral agents
macrocyclic compounds
ritonavir
sulfonamides
uracil
treatment outcome
insurance, health, reimbursement
Hepatitis C virus genotype 1 (organism)
ombitasvir
dasabuvir
paritaprevir
dasabuvir
ombitasvir, paritaprevir and ritonavir
ombitasvir
dasabuvir
paritaprevir
---
http://www.has-sante.fr/portail/jcms/c_2736733/fr/cabometyx
http://www.has-sante.fr/portail/jcms/c_2736733/fr/cabometyx-cabozantinib-inhibiteur-de-tyrosine-kinase
2017
false
false
false
France
French
treatment outcome
cabozantinib
anilides
pyridines
cabozantinib
carcinoma, renal cell
Advanced Malignant Neoplasm
Cabozantinib S-malate
receptor Protein-Tyrosine kinases
administration, oral
adult
protein kinase inhibitors
protein kinase inhibitors
survival analysis
evaluation of the transparency committee
clear cell renal cell carcinoma
guidelines for drug use
Tyrosine Kinase Inhibitors
cabozantinib
anilides
pyridines
---
http://www.has-sante.fr/portail/jcms/c_2633680/fr/antiviraux-d-action-directe
2016
false
false
false
France
French
evaluation of the transparency committee
adult
hepatitis C, chronic
drug therapy, combination
Sofosbuvir
antiviral agents
direct acting antivirals
daclatasvir
Simeprevir
ledipasvir, sofosbuvir drug combination
dasabuvir
drug combinations
ombitasvir
ritonavir
paritaprevir
fibrosis, liver
risk
has patient
hepacivirus
Infections
autoimmune diseases
hepatic fibrosis, nos
fibrosis
hepatitis C virus
human enterovirus 72
hepatitis C, chronic
business
liver cirrhosis
socialism
patients
chronic infectious disease
guideline
antiviral agents
chronic hepatitis, nos
health
case management
hepatitis c virus
hepatitis a virus
dasabuvir
ombitasvir
paritaprevir
daclatasvir
fibrosis
commerce
patients
guideline
benzimidazoles
fluorenes
uridine monophosphate
sulfonamides
uracil
uracil
anilides
carbamates
macrocyclic compounds
imidazoles
---
http://www.e-cancer.fr/Expertises-et-publications/Catalogue-des-publications/Medicaments-inhibiteurs-de-la-voie-Hedgehog-vismodegib
2016
false
false
false
France
French
administration, oral
Drug-Related side effects and adverse reactions
guidelines for drug use
patients guideline
practice guideline
vismodegib
vismodegib
vismodegib
vismodegib
antineoplastic agents
antineoplastic agents
antineoplastic agents
carcinoma, basal cell
pregnancy
drug interactions
interdisciplinary communication
Hedgehog Signaling Pathway
signal transduction
hedgehog proteins
continuity of patient care
drug monitoring
HhAntag691
HhAntag691
HhAntag691
anilides
pyridines
anilides
pyridines
anilides
pyridines
---
https://ansm.sante.fr/tableau-atu-rtu/cabometyx-20-mg-40-mg-et-60-mg-comprime-pellicule
2016
false
false
false
France
French
cabozantinib
cabozantinib
guidelines for drug use
summary of product characteristics
package leaflet
cabozantinib
seborrhea sicca
dandruff
compression, nos
tablets
pill, nos
dandruff
anilides
pyridines
anilides
pyridines
---
https://www.hc-sc.gc.ca/dhp-mps/medeff/bulletin/hpiw-ivps_2016-12-page2-fra.php#eriv
2016
false
false
false
Canada
French
English
pharmacovigilance note
vismodegib
vismodegib
child
adolescent
vismodegib
premature epiphyseal closure
bone diseases
HhAntag691
HhAntag691
anilides
pyridines
anilides
pyridines
Contraindications, Drug
---
http://www.has-sante.fr/portail/jcms/c_2728866/fr/reevaluation-des-antiviraux-d-action-directe-dans-le-traitement-de-l-hepatite-c
2016
false
false
false
France
French
guidelines for drug use
practice guideline
antiviral agents
hepatitis C, chronic
drug evaluation
Sofosbuvir
administration, oral
Simeprevir
direct acting antivirals
daclatasvir
ledipasvir
ledipasvir, sofosbuvir drug combination
drug therapy, combination
ritonavir
ombitasvir
paritaprevir
dasabuvir
drug resistance, viral
drug interactions
treatment outcome
daclatasvir
ombitasvir
paritaprevir
dasabuvir
benzimidazoles
fluorenes
uridine monophosphate
uridine monophosphate
imidazoles
anilides
carbamates
macrocyclic compounds
sulfonamides
uracil
uracil
---
https://www.ema.europa.eu/medicines/human/EPAR/Cabometyx
2016
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
cabozantinib
anilides
pyridines
cabozantinib
drug approval
europe
drug interactions
pregnancy
breast feeding
carcinoma, renal cell
Advanced Malignant Neoplasm
Cabozantinib S-malate
receptor Protein-Tyrosine kinases
administration, oral
tablets
adult
protein kinase inhibitors
protein kinase inhibitors
risk assessment
product surveillance, postmarketing
survival analysis
drug evaluation, preclinical
Tyrosine Kinase Inhibitors
cabozantinib
anilides
pyridines
---
Viekirax - ombitasvir / paritaprevir / ritonavir
https://www.ema.europa.eu/medicines/human/EPAR/Viekirax
2015
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug combinations
anilides
anilides
drug approval
europe
carbamates
carbamates
hepatitis C, chronic
drug therapy, combination
antiviral agents
antiviral agents
macrocyclic compounds
macrocyclic compounds
ritonavir
ritonavir
administration, oral
cytochrome p-450 cyp3a
NS-5 protein, hepatitis C virus
NS4A cofactor peptide, hepatitis C virus
NS3 protein, hepatitis C virus
product surveillance, postmarketing
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
ombitasvir
ombitasvir
paritaprevir
paritaprevir
paritaprevir
paritaprevir
ombitasvir, paritaprevir and ritonavir
viral nonstructural proteins
carrier proteins
viral nonstructural proteins
ombitasvir
ombitasvir
---
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00250
2015
false
false
false
Canada
French
English
drug information
Product containing ombitasvir and paritaprevir and ritonavir in oral dose form (medicinal
product form)
drug combinations
ritonavir
paritaprevir
ombitasvir
ombitasvir, paritaprevir and ritonavir
paritaprevir
ombitasvir
macrocyclic compounds
anilides
carbamates
---
http://www.has-sante.fr/portail/jcms/c_2025737/fr/exviera/viekirax
http://www.has-sante.fr/portail/jcms/c_2025737/fr/viekirax-ombitasvir/paritaprevir/ritonavir-association-fixe-dantiviraux-a-action-directe-exviera-dasabuvir-antiviral-a-action-directe
2015
false
false
false
France
French
evaluation of the transparency committee
guidelines for drug use
drug combinations
administration, oral
hepatitis C, chronic
drug therapy, combination
adult
anilides
anilides
carbamates
carbamates
antiviral agents
antiviral agents
macrocyclic compounds
macrocyclic compounds
ritonavir
ritonavir
sulfonamides
sulfonamides
uracil
treatment outcome
insurance, health, reimbursement
Hepatitis C virus genotype 1 (organism)
Hepatitis C virus genotype 4 (organism)
ombitasvir
paritaprevir
dasabuvir
paritaprevir
dasabuvir
ombitasvir, paritaprevir and ritonavir
ombitasvir
dasabuvir
---
Information Update - Risk of Serious Liver Injury associated with Hepatitis C Treatments:
Holkira Pak and Technivie
https://canadiensensante.gc.ca/recall-alert-rappel-avis/hc-sc/2015/55800a-fra.php
2015
false
false
false
Canada
French
English
Chemical and Drug Induced Liver Injury
pharmacovigilance note
antiviral agents
hepatitis C, chronic
drug combinations
antiviral agents
ombitasvir
paritaprevir
ritonavir
dasabuvir
ombitasvir
dasabuvir
anilides
carbamates
sulfonamides
uracil
uracil
macrocyclic compounds
Contraindications, Drug
---
http://www.has-sante.fr/portail/jcms/c_1721873/fr/erivedge-vismodegib-antineoplasique
2014
false
false
false
France
French
English
guidelines for drug use
evaluation of the transparency committee
treatment outcome
administration, oral
vismodegib
vismodegib
vismodegib
antineoplastic agents
antineoplastic agents
carcinoma, basal cell
neoplasm metastasis
adult
insurance, health, reimbursement
HhAntag691
HhAntag691
anilides
pyridines
anilides
pyridines
---
http://www.has-sante.fr/portail/jcms/c_2007291/fr/cometriq
http://www.has-sante.fr/portail/jcms/c_2007291/fr/cometriq-cabozantinib-inhibiteur-de-tyrosine-kinase
2014
false
false
false
France
French
evaluation of the transparency committee
guidelines for drug use
anilides
anilides
pyridines
pyridines
receptor Protein-Tyrosine kinases
neoplasm metastasis
adult
thyroid cancer, medullary
treatment outcome
survival analysis
antineoplastic agents
antineoplastic agents
administration, oral
insurance, health, reimbursement
cabozantinib
late
Progression-Free survival
protein kinase inhibitors
protein kinase inhibitors
cabozantinib
cabozantinib
Tyrosine Kinase Inhibitors
disease-free survival
thyroid neoplasms
---
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00212
2013
false
false
false
Canada
Product containing precisely vismodegib 150 milligram/1 each conventional release
oral capsule (clinical drug)
vismodegib
vismodegib
drug information
HhAntag691
anilides
pyridines
---